Tenet Healthcare (NYSE:THC) Sets New 52-Week High Following Earnings Beat

Tenet Healthcare Corporation (NYSE:THC)’s share price reached a new 52-week high on Thursday after the company announced better than expected quarterly earnings. The stock traded as high as $229.00 and last traded at $225.86, with a volume of 3392868 shares traded. The stock had previously closed at $193.04.

The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.05 by $0.65. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.During the same quarter in the previous year, the business earned $3.44 EPS. The firm’s revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS.

Trending Headlines about Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Q4 earnings beat and revenue acceleration — Tenet reported $4.70 EPS vs. consensus ~ $4.05 and revenue rose ~8.9% year‑over‑year (~$5.53B), driven by hospital and ambulatory surgery demand. Tenet Healthcare Profit Rises on Ambulatory and Hospital Revenue Growth
• Positive Sentiment: Raised/clear FY‑2026 targets and EBITDA range — Management provided 2026 EPS guidance and an adjusted‑EBITDA target ($4.485B–$4.785B), signaling confidence in continued margin expansion and cash flow. Tenet Healthcare outlines $4.485B–$4.785B 2026 adjusted EBITDA target
• Positive Sentiment: Management commentary and investor materials emphasize structural cost initiatives and M&A as levers to sustain growth and margins, reinforcing the outlook. Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook
• Positive Sentiment: Market reaction — Coverage notes the stock hit record highs and traded on heavy volume after the release, indicating broad investor enthusiasm. Tenet Healthcare stock rises after Q4 beat
• Neutral Sentiment: Full‑year guidance range vs. consensus — Tenet gave an EPS range (16.19–18.47) and revenue range ($21.5B–$22.3B) that broadly brackets analyst expectations; midpoint is roughly close to consensus but leaves room for execution risk. Tenet Healthcare beats Q4 expectations, issues solid 2026 outlook
• Negative Sentiment: Earlier concerns about patient‑day trends — Pre‑earnings commentary flagged that lower hospital patient days could pressure margins if the trend extended; investors will watch operating metrics closely in coming quarters. Will Lower Patient Days Affect Tenet Healthcare’s Q4 Earnings?

Analyst Upgrades and Downgrades

A number of research firms have weighed in on THC. Truist Financial reaffirmed a “buy” rating and set a $240.00 price target (up previously from $225.00) on shares of Tenet Healthcare in a research note on Monday, November 3rd. Weiss Ratings upgraded Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, December 29th. Barclays raised their price objective on Tenet Healthcare from $229.00 to $240.00 and gave the stock an “overweight” rating in a report on Friday, November 21st. Morgan Stanley reiterated an “overweight” rating and set a $247.00 target price on shares of Tenet Healthcare in a report on Thursday, December 18th. Finally, Guggenheim raised their price target on shares of Tenet Healthcare from $238.00 to $257.00 and gave the company a “buy” rating in a report on Tuesday, December 2nd. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $233.88.

Insiders Place Their Bets

In related news, Director Nadja West sold 2,178 shares of the company’s stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the sale, the director owned 28,480 shares of the company’s stock, valued at $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.81% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in THC. Triumph Capital Management bought a new position in Tenet Healthcare during the 3rd quarter valued at $25,000. Activest Wealth Management acquired a new position in Tenet Healthcare during the fourth quarter worth about $26,000. Elyxium Wealth LLC acquired a new stake in Tenet Healthcare in the 4th quarter valued at about $29,000. William B. Walkup & Associates Inc. bought a new position in shares of Tenet Healthcare during the 3rd quarter valued at about $32,000. Finally, Westside Investment Management Inc. raised its holdings in shares of Tenet Healthcare by 100.0% in the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after purchasing an additional 96 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Trading Up 17.0%

The company has a quick ratio of 1.64, a current ratio of 1.71 and a debt-to-equity ratio of 2.27. The firm has a market capitalization of $19.85 billion, a price-to-earnings ratio of 15.48, a price-to-earnings-growth ratio of 0.82 and a beta of 1.44. The firm’s 50 day moving average is $198.00 and its 200 day moving average is $193.90.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.